Eric D. Andersen's Insider Trades & SAST Disclosures
Eric D. Andersen's most recent trade in Merrimack Pharmaceuticals Inc was a trade of 48,693 Common Stock done at an average price of $13.2 . Disclosure was reported to the exchange on Dec. 26, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eric D. Andersen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merrimack Pharmaceuticals Inc | D. Eric Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 13.15 per share. | 26 Dec 2023 | 48,693 | 533,151 (3%) | 0% | 13.2 | 640,313 | Common Stock |
| Merrimack Pharmaceuticals Inc | D. Andersen Eric | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 13.35 per share. | 26 Dec 2023 | 857 | 534,008 (3%) | 0% | 13.4 | 11,441 | Common Stock |
| Merrimack Pharmaceuticals Inc | Andersen Eric D. | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 12.85 per share. | 07 Dec 2023 | 76,384 | 1,735,600 (12%) | 0% | 12.8 | 981,519 | Common Stock |
| Merrimack Pharmaceuticals Inc | D. Andersen Eric | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 12.85 per share. | 07 Dec 2023 | 24,666 | 484,458 (3%) | 0% | 12.8 | 316,953 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 07 Aug 2023 | 84,636 | 1,496,680 (11%) | 0% | 12.0 | 1,015,945 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 07 Aug 2023 | 68,431 | 1,565,111 (11%) | 0% | 12.0 | 820,891 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 07 Aug 2023 | 49,857 | 407,371 (3%) | 0% | 12.0 | 598,468 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 07 Aug 2023 | 18,626 | 425,997 (3%) | 0% | 12.0 | 223,436 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.52 per share. | 21 Mar 2023 | 127,409 | 1,412,044 (10%) | 0% | 11.5 | 1,467,752 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.52 per share. | 21 Mar 2023 | 33,181 | 357,514 (2%) | 0% | 11.5 | 382,245 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.36 per share. | 30 Jan 2023 | 19,750 | 1,282,853 (9%) | 0% | 11.4 | 224,313 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.36 per share. | 30 Jan 2023 | 4,985 | 323,883 (2%) | 0% | 11.4 | 56,618 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.40 per share. | 30 Jan 2023 | 1,782 | 1,284,635 (9%) | 0% | 11.4 | 20,314 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.40 per share. | 30 Jan 2023 | 450 | 324,333 (2%) | 0% | 11.4 | 5,130 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.40 per share. | 27 Jan 2023 | 17,465 | 1,263,103 (9%) | 0% | 11.4 | 199,040 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.40 per share. | 27 Jan 2023 | 4,410 | 318,898 (2%) | 0% | 11.4 | 50,259 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.33 per share. | 03 Jan 2023 | 22,413 | 1,245,638 (9%) | 0% | 11.3 | 254,011 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.33 per share. | 03 Jan 2023 | 8,219 | 314,488 (2%) | 0% | 11.3 | 93,148 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 10.55 per share. | 29 Dec 2022 | 189,975 | 1,190,195 (8%) | 1% | 10.6 | 2,004,293 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.33 per share. | 29 Dec 2022 | 33,030 | 1,223,225 (9%) | 0% | 11.3 | 374,319 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 10.55 per share. | 29 Dec 2022 | 28,661 | 297,999 (2%) | 0% | 10.6 | 302,382 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 11.33 per share. | 29 Dec 2022 | 8,270 | 306,269 (2%) | 0% | 11.3 | 93,721 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Sale of securities on an exchange or to another person at price $ 6.39 per share. | 14 Apr 2021 | 52,914 | 269,338 (2%) | 0% | 6.4 | 338,120 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 6.39 per share. | 14 Apr 2021 | 52,914 | 1,000,220 (7%) | 0% | 6.4 | 338,120 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 6.63 per share. | 14 Apr 2021 | 40,805 | 947,306 (7%) | 0% | 6.6 | 270,655 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 6.63 per share. | 14 Apr 2021 | 6,495 | 322,252 (2%) | 0% | 6.6 | 43,081 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 6.26 per share. | 13 Apr 2021 | 9,874 | 906,591 (6%) | 0% | 6.3 | 61,780 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 6.06 per share. | 12 Apr 2021 | 23,629 | 896,717 (6%) | 0% | 6.1 | 143,194 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 24 Nov 2020 | 51,074 | 873,088 (6%) | 0% | 3.6 | 186,420 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 24 Nov 2020 | 18,014 | 315,757 (2%) | 0% | 3.6 | 65,751 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 12 Nov 2020 | 54,531 | 297,743 (2%) | 0% | 3.6 | 199,038 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Director, See remarks | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 12 Nov 2020 | 1,959 | 822,014 (6%) | 0% | 3.6 | 7,150 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 13 Aug 2020 | 609 | 820,055 (6%) | 0% | 3.5 | 2,132 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.45 per share. | 11 Aug 2020 | 14,030 | 241,212 (1%) | 0% | 3.5 | 48,437 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 11 Aug 2020 | 2,000 | 243,212 (1%) | 0% | 3.5 | 6,986 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.04 per share. | 22 Jul 2020 | 63,903 | 819,446 (6%) | 0% | 3.0 | 194,387 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 22 Jul 2020 | 62,775 | 755,543 (5%) | 0% | 3.2 | 201,006 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.04 per share. | 22 Jul 2020 | 33,192 | 227,182 (1%) | 0% | 3.0 | 100,967 | Common Stock |
| Merrimack Pharmaceuticals Inc | Eric D. Andersen | Other, See remarks | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 22 Jul 2020 | 17,404 | 193,990 (1%) | 0% | 3.2 | 55,728 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges